All Stories

  1. Development of an In Vitro Human Thyroid Microtissue Model for Chemical Screening
  2. The next generation blueprint of computational toxicology at the U.S. Environmental Protection Agency
  3. DEVELOPMENT OF A CURATED HERSHBERGER DATABASE
  4. Accelerating the Pace of Chemical Risk Assessment
  5. Aryl hydrocarbon receptor knockout rats are insensitive to the pathological effects of repeated oral exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin
  6. Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model
  7. Technical guide for applications of gene expression profiling in human health risk assessment of environmental chemicals
  8. Predicting Hepatotoxicity Using ToxCastin VitroBioactivity and Chemical Structure
  9. Identifying genes that mediate anthracyline toxicity in immune cells
  10. Correction: Identification of Modulators of the Nuclear Receptor Peroxisome Proliferator-Activated Receptor α (PPARα) in a Mouse Liver Gene Expression Compendium
  11. Identification of Modulators of the Nuclear Receptor Peroxisome Proliferator-Activated Receptor α (PPARα) in a Mouse Liver Gene Expression Compendium
  12. Immune cell-based screening assay for response to anticancer agents: applications in pharmacogenomics
  13. Lineage‐dependent effects of aryl hydrocarbon receptor agonists contribute to liver tumorigenesis
  14. The Human Toxome Project
  15. MYC Is an Early Response Regulator of Human Adipogenesis in Adipose Stem Cells
  16. Aryl hydrocarbon receptor knock‐out exacerbates choroidal neovascularization via multiple pathogenic pathways
  17. Transcriptional responses in the rat nasal epithelium following subchronic inhalation of naphthalene vapor
  18. A cellular genetics approach identifies gene-drug interactions and pinpoints drug toxicity pathway nodes
  19. Incorporating Population Variability and Susceptible Subpopulations into Dosimetry for High-Throughput Toxicity Testing
  20. Development of 3D Dynamic Flow Model of Human Liver and Its Application to Prediction of Metabolic Clearance of 7-Ethoxycoumarin
  21. In Vitroand Modelling Approaches to Risk Assessment from the U.S. Environmental Protection Agency ToxCast Programme
  22. Erratum
  23. EN
  24. IVT-seq reveals extreme bias in RNA sequencing
  25. Comparison of Microarrays and RNA-Seq for Gene Expression Analyses of Dose-Response Experiments
  26. Subchronic toxicity evaluation of potassium bromate in Fischer 344 rats
  27. Aryl hydrocarbon receptor deficiency causes dysregulated cellular matrix metabolism and age-related macular degeneration-like pathology
  28. Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice
  29. A Genomics-Based Analysis of Relative Potencies of Dioxin-Like Compounds in Primary Rat Hepatocytes
  30. A Multi-Stakeholder Perspective on the Use of Alternative Test Strategies for Nanomaterial Safety Assessment
  31. Subchronic Toxicity Evaluation of Anthraquinone in Fischer 344 Rats
  32. Incorporating New Technologies Into Toxicity Testing and Risk Assessment: Moving From 21st Century Vision to a Data-Driven Framework
  33. Biological Networks for Predicting Chemical Hepatocarcinogenicity Using Gene Expression Data from Treated Mice and Relevance across Human and Rat Species
  34. Temporal Concordance Between Apical and Transcriptional Points of Departure for Chemical Risk Assessment
  35. All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin
  36. Incorporating Human Dosimetry and Exposure Information with High-Throughput Screening Data in Chemical Toxicity Assessment
  37. Relative Impact of Incorporating Pharmacokinetics on Predicting In Vivo Hazard and Mode of Action from High-Throughput In Vitro Toxicity Assays
  38. The Aryl-Hydrocarbon Receptor Protein Interaction Network (AHR-PIN) as Identified by Tandem Affinity Purification (TAP) and Mass Spectrometry
  39. Evaluation of gene expression changes in human primary uroepithelial cells following 24-Hr exposures to inorganic arsenic and its methylated metabolites
  40. Cross-Species Transcriptomic Analysis of Mouse and Rat Lung Exposed to Chloroprene
  41. Subchronic Hepatotoxicity Evaluation of Hydrazobenzene in Fischer 344 Rats
  42. Response to "Incorporating Biological, Chemical, and Toxicological Knowledge Into Predictive Models of Toxicity"
  43. Subchronic urinary bladder toxicity evaluation of N-Nitrosodiphenylamine in Fischer 344 rats
  44. Integrating pathway-based transcriptomic data into quantitative chemical risk assessment: A five chemical case study
  45. Subchronic Thyroid Toxicity Evaluation of 4,4′-Methylenebis(N,N′-Dimethyl)Aniline in Fischer 344 Rats
  46. A Comprehensive Statistical Analysis of Predicting In Vivo Hazard Using High-Throughput In Vitro Screening
  47. Response to "Accurate Risk-Based Chemical Screening * Relies on Robust Exposure Estimates"
  48. Subchronic Hepatotoxicity Evaluation of 1,2,4-Tribromobenzene in Sprague-Dawley Rats
  49. Subchronic hepatotoxicity evaluation of bromobenzene in Fischer 344 rats
  50. Cross-species Comparisons of Transcriptomic Alterations in Human and Rat Primary Hepatocytes Exposed to 2,3,7,8-Tetrachlorodibenzo-p-dioxin
  51. Biological responses in rats exposed to cigarette smoke and Middle East sand (dust)
  52. Subchronic Hepatotoxicity Evaluation of 2,3,4,6-Tetrachlorophenol in Sprague Dawley Rats
  53. Integration of Dosimetry, Exposure, and High-Throughput Screening Data in Chemical Toxicity Assessment
  54. The aryl hydrocarbon receptor interacts with ATP5α1, a subunit of the ATP synthase complex, and modulates mitochondrial function
  55. Concentration- and Time-dependent Genomic Changes in the Mouse Urinary Bladder Following Exposure to Arsenate in Drinking Water for up to 12 Weeks
  56. Analysis of Transcriptomic Dose-Response Data for Toxicology and Risk Assessment
  57. Estimating Toxicity-Related Biological Pathway Altering Doses for High-Throughput Chemical Risk Assessment
  58. Regulation of Bach2 by the aryl hydrocarbon receptor as a mechanism for suppression of B-cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin
  59. Systems pharmacology assessment of the 5-fluorouracil pathway
  60. Application of Transcriptional Benchmark Dose Values in Quantitative Cancer and Noncancer Risk Assessment
  61. Formaldehyde: Integrating Dosimetry, Cytotoxicity, and Genomics to Understand Dose-Dependent Transitions for an Endogenous Compound
  62. An Integrated Genomic Analysis of Aryl Hydrocarbon Receptor-Mediated Inhibition of B-Cell Differentiation
  63. Functional analysis of multiple genomic signatures demonstrates that classification algorithms choose phenotype-related genes
  64. A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression data
  65. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
  66. The Identification of Protein Kinase C Iota as a Regulator of the Mammalian Heat Shock Response Using Functional Genomic Screens
  67. Genome-wide Analysis of DNA Methylation and Gene Expression Changes in the Mouse Lung following Subchronic Arsenate Exposure
  68. Incorporating Human Dosimetry and Exposure into High-Throughput In Vitro Toxicity Screening
  69. Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury
  70. Activation of the Aryl-Hydrocarbon Receptor Inhibits Invasive and Metastatic Features of Human Breast Cancer Cells and Promotes Breast Cancer Cell Differentiation
  71. A Bistable Switch Underlying B-Cell Differentiation and Its Disruption by the Environmental Contaminant 2,3,7,8-Tetrachlorodibenzo-p-dioxin
  72. Expression profiling in canine osteosarcoma: identification of biomarkers and pathways associated with outcome
  73. Stochastic Modeling of B Lymphocyte Terminal Differentiation and Its Suppression by Dioxin
  74. Regulation of Aryl Hydrocarbon Receptor Function by Selective Estrogen Receptor Modulators
  75. Aryl Hydrocarbon Receptor Regulates Cell Cycle Progression in Human Breast Cancer Cells via a Functional Interaction with Cyclin-Dependent Kinase 4
  76. Use of Short-term Transcriptional Profiles to Assess the Long-term Cancer-Related Safety of Environmental and Industrial Chemicals
  77. Dose-dependent transitions in Nrf2-mediated adaptive response and related stress responses to hypochlorous acid in mouse macrophages
  78. In utero exposure to chloroquine alters sexual development in the male fetal rat
  79. Gene Expression Changes Following Acute Hydrogen Sulfide (H2S)-induced Nasal Respiratory Epithelial Injury
  80. Genomic Signatures and Dose-Dependent Transitions in Nasal Epithelial Responses to Inhaled Formaldehyde in the Rat
  81. Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: A progress report
  82. Application of Genomic Biomarkers to Predict Increased Lung Tumor Incidence in 2-Year Rodent Cancer Bioassays
  83. A Method to Integrate Benchmark Dose Estimates with Genomic Data to Assess the Functional Effects of Chemical Exposure
  84. Biologically Motivated Approaches to Extrapolation from High to Low Doses and the Advent of Systems Biology: The Road to Toxicological Safety Assessment
  85. Genomic analysis of human lung fibroblasts exposed to vanadium pentoxide to identify candidate genes for occupational bronchitis
  86. BMDExpress: a software tool for the benchmark dose analyses of genomic data
  87. Basal Gene Expression in Male and Female Sprague-Dawley Rat Nasal Respiratory and Olfactory Epithelium
  88. A functional map of NFκB signaling identifies novel modulators and multiple system controls
  89. A Comparison of Transcriptomic and Metabonomic Technologies for Identifying Biomarkers Predictive of Two-Year Rodent Cancer Bioassays
  90. Genome-wide analysis of human HSF1 signaling reveals a transcriptional program linked to cellular adaptation and survival
  91. New directions in incidence–dose modeling
  92. EDGE: A Centralized Resource for the Comparison, Analysis, and Distribution of Toxicogenomic Information
  93. Dose–response modeling in reproductive toxicology in the systems biology era
  94. Chemical mixture toxicology: from descriptive to mechanistic, and going on to in silico toxicology
  95. Genome-scale functional profiling of the mammalian AP-1 signaling pathway
  96. Stochastic Simulation of Hepatic Preneoplastic Foci Development for Four Chlorobenzene Congeners in a Medium-Term Bioassay
  97. Sequence variation and phylogenetic history of the mouse Ahr gene
  98. Developing toxicologically predictive gene sets using cDNA microarrays and bayesian classification
  99. The Sequence of the Human Genome
  100. A Physiologically Based Pharmacodynamic Analysis of Hepatic Foci within a Medium-Term Liver Bioassay Using Pentachlorobenzene as a Promoter and Diethylnitrosamine as an Initiator
  101. Evidence for hepatocarcinogenic activity of pentachlorobenzene with intralobular variation in foci incidence
  102. Use of a medium-term liver focus bioassay to assess the hepatocarcinogenicity of 1,2,4,5-tetrachlorobenzene and 1,4-dichlorobenzene
  103. Enhanced Regional Expression of GlutathioneS-Transferase P1-1 with Colocalized AP-1 and CYP 1A2 Induction in Chlorobenzene-Induced Porphyria
  104. Physiologically based pharmacokinetic/pharmacodynamic modeling of the toxicologic interaction between carbon tetrachloride and Kepone
  105. Incorporating Monte Carlo Simulation into Physiologically Based Pharmacokinetic Models Using Advanced Continuous Simulation Language (ACSL): A Computational Method
  106. The use of physiologically-based pharmacokinetic/ pharmacodynamic dosimetry models for chemical mixtures
  107. Physiologically based pharmacokinetic/pharmacodynamic modeling of chemical mixtures and possible applications in risk assessment
  108. The application of physiologically based pharmacokinetic/ pharmacodynamic (PBPK/PD) modeling for exploring risk assessment approaches of chemical mixtures